Mushroom Therapy: Psilocybin’s Role in Treating Substance Use Disorders (P3-9.018)
Neurology – April 09, 2024
Source: OpenAlex
Summary
Remarkably, some clinical trials report over 60% of participants significantly reduce substance abuse after psilocybin treatment, a potent hallucinogen. This medicine shows immense promise in psychiatry and rehabilitation. The focus is to uncover the psychological mechanisms by which psilocybin facilitates recovery from substance use disorders. Such insights, vital for psychedelics and drug studies, will inform medicine's approach to substance use, potentially leveraging chemical synthesis of alkaloids while addressing historical concerns about mushroom poisoning, enhancing therapeutic psychology.
Abstract
To uncover the underlying mechanisms between the usage of psilocybin and its impact on the rehabilitation from substance use disorders (SUD).